About CMR Naviscan
CMR Naviscan is a company based in San Diego (United States) founded in 1995 was acquired by CMR in December 2013. CMR Naviscan has raised $29.85 million across 8 funding rounds from investors including QuestMark Partners, Sanderling Ventures and Walker Ventures. CMR Naviscan operates in a competitive market with competitors including Delphinus Medical Technologies, CairnSurgical, Oncovision, Niramai and QT Imaging, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Naviscan, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29.85 M (USD)
in 8 rounds
-
Latest Funding Round
$1 M (USD), Series C
Dec 18, 2012
-
Investors
QuestMark Partners
& 4 more
-
Employee Count
Not available
-
Acquired by
CMR
(Dec 11, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CMR Naviscan
CMR Naviscan has successfully raised a total of $29.85M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $1 million completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CMR Naviscan
CMR Naviscan has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include QuestMark Partners, Sanderling Ventures and Walker Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Expansion stage tech-focused VC firm investing primarily in the US
|
Locked | Locked | Locked | |
|
Biomedical investment financing and active management services.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for CMR Naviscan
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CMR Naviscan
Investment portfolio details for CMR Naviscan
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CMR Naviscan
Detailed financials for CMR Naviscan
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cmr Naviscan Comparisons
Peer comparison for CMR Naviscan
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CMR Naviscan
CMR Naviscan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Delphinus Medical Technologies, CairnSurgical, Oncovision, Niramai and QT Imaging, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform for breast ultrasound imaging
|
|
| Locked | Locked | Locked |
Developer of 3D printed surgical guides for breast cancer treatment
|
|
| Locked | Locked | Locked |
Diagnostic imaging devices for oncology are manufactured and provided.
|
|
| Locked | Locked | Locked |
Early breast cancer is detected using AI-based non-invasive thermal imaging.
|
|
| Locked | Locked | Locked |
Non-invasive ultrasound device for breast cancer detection is developed.
|
|
| Locked | Locked | Locked |
Devices and software for wellness and medical uses are provided.
|
Detailed competitors of CMR Naviscan
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cmr Naviscan
Complete news archive for CMR Naviscan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CMR Naviscan
CMR Naviscan was founded in 1995 and raised its 1st funding round 10 years after it was founded.
CMR Naviscan is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Paul Mirabella is the current CEO of CMR Naviscan.
CMR Naviscan is a funded company, having raised a total of $29.85M across 8 funding rounds to date.
CMR Naviscan was established in 1995 in San Diego, United States, within the medical imaging sector. Organ-specific molecular imaging systems, particularly high-resolution positron emission tomography (PET) scanners, are designed, manufactured, and distributed for breast cancer detection and monitoring. Key products include the Naviscan Solo II for treatment evaluation, the Stereo Navigator for biopsy procedures, and the MIMViewer platform for image analysis and viewing.
CMR Naviscan's top competitors include Delphinus Medical Technologies, QT Imaging and CairnSurgical.
CMR Naviscan has 5 investors. Key investors include QuestMark Partners, Sanderling Ventures, Walker Ventures, Mayo Clinic Business Accelerator, and CMR.